Genascence
Palo Alto
About Genascence
Genascence is a clinical-stage biotechnology company that is using gene therapy to revolutionize the treatment of common musculoskeletal diseases. The company intends to tackle one of the most serious problems in medicine: osteoarthritis, which is the leading cause of disability, chronic pain, and a significant risk factor for opioid addiction (OA).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $100K – $500K
- Total funding: $27.1M
- Funding stage: Early Stage Venture
- Last round: Grant (Feb 2023)
- Website: genascence.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/genascence-62634 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.